Video

'Vogl, New York' offers San Antonio perspectives

Publish date: December 16, 2013

 

In an interview with Frontline Medical News, New York oncologist and San Antonio Breast Cancer Symposium star gadfly Dr. Steven Vogl gives his quick take on several of the studies making news at this year's meeting.

Recommended Reading

Radiotherapy can be omitted for many older breast cancer patients
MDedge Hematology and Oncology
VIDEO: Tumor-infiltrating lymphocytes may predict trastuzumab success
MDedge Hematology and Oncology
Dasatinib gives letrozole a boost in HR-positive advanced breast cancer
MDedge Hematology and Oncology
IBIS-II: Anastrozole highly effective in preventing breast cancer
MDedge Hematology and Oncology
Surgery adds little after successful chemo in metastatic breast cancer
MDedge Hematology and Oncology
Exercise dampens aromatase inhibitor–related joint pain
MDedge Hematology and Oncology
SABCS Roundtable with Dr. Howard Burris and Dr. William Gradishar
MDedge Hematology and Oncology
No survival benefit to bisphosphonate in chemoresistant breast cancer
MDedge Hematology and Oncology
New mega-review underscores mammography’s benefits
MDedge Hematology and Oncology
Veliparib-carboplatin combo is first 'graduate' of I-SPY2 trial
MDedge Hematology and Oncology